Photo

Photo detail

Photo Courtesy of INOVIO
INOVIO began developing its COVID-19 vaccine back in January 2020 and so far it has tested in trials to have an effective response against variants.

Stories this photo appears in:

INOVIO Advances COVID-19 Vaccine Trials

BIOTECH: Co. Moves Forward in Mexico, Brazil and the Philippines

INOVIO Pharmaceuticals (NASDAQ: INO), a biotechnology company designing DNA medicines, received approval from Mexico’s national health regulatory agency to advance its COVID-19 vaccine candidate to Phase 3 clinical trials.

Tease photo